Dressing material for the treatment of wounds, and corpuscles for use in the production thereof
Patent 5147339 Issued on September 15, 1992. Estimated Expiration Date: 
September 15, 2009. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
September 15, 2009. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3742951 Dressings, granules, and their use in treating wounds Method of transdermal drug delivery Self-adhesive plaster containing medication Method comprising transdermal and buccal treatment of angina Patent #: 4704119 InventorAssigneeApplicationNo. 375019 filed on 05/31/1989US Classes:604/307, Adhesively attachable to body424/447, Bandages with incorporated medicaments523/111, Compositions for use in tape adhesives, binder or impregnate for a body fluid adsorbent device, e.g., a surgical adhesive tape, etc.602/56, Absorbent604/304Bandage, pad, or shield placed on body for sustained treatment thereofExaminersPrimary: Green, Randall L.Assistant: Prebilic, Paul B. Attorney, Agent or FirmForeign Patent References
International ClassA61F 013/02Foreign Application Priority Data1987-09-22 DKAbstractA dressing material for the treatment of wounds comprises a dressing and corpuscles which are placed on or may be placed on the dressing, most frequently by means of an irreversible adhesive connection, and which contains at least one substance which is active in wound care. The corpuscles consist of a solid, continuous, hydrophobic, biologically inert, water-insoluble matrix which is stable at temperatures below 50°C. and which contains at least one hydrophilic, discontinuous phase in which one or more biologically active substances are dispersed, dissolved or are present as a coating thereon. As active substances may for example be used EGF (epidermal growth factor) EGF-urogastron, immunoglobulines, antiseptics, antibiotics, antiinflammatory agents, proteolytics and local anaesthetics, heparin and vasodilators.Field of SearchBandage, pad, or shield placed on body for sustained treatment thereofAdhesively attachable to body CONTROLLED RELEASE THERAPEUTIC DEVICE OR SYSTEM Gas produced in situ by chemical reaction Bandages with incorporated medicaments Pressure sensitive adhesive means Compositions for use in tape adhesives, binder or impregnate for a body fluid adsorbent device, e.g., a surgical adhesive tape, etc. Absorbent | |
